Research Papers

24 of 1549 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Update on the optimal use of voriconazole for invasive fungal infections.
Lat A; Thompson GR.
Infect Drug Resist (Unknown)
Published: 2011
2/6 Transparent
Funding Declared
Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis.
Sordé R; Pahissa A; Rello J.
Infect Drug Resist (Unknown)
Published: 2011
1/6 Transparent
Management of Chlamydia trachomatis genital tract infection: screening and treatment challenges.
Taylor BD; Haggerty CL.
Infect Drug Resist (Unknown)
Published: 2011
1/6 Transparent
Current treatment of choice for chronic hepatitis C infection.
Yasin T; Riley TR; Schreibman IR.
Infect Drug Resist (Unknown)
Published: 2011
1/6 Transparent
Lyme disease: the next decade.
Stricker RB; Johnson L.
Infect Drug Resist (Unknown)
Published: 2011
2/6 Transparent
Funding Declared
Current strategies for the prevention and management of central line-associated bloodstream infections.
Han Z; Liang SY; Marschall J.
Infect Drug Resist (Unknown)
Published: 2010
1/6 Transparent
New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting ant…
Quer J; Buti M; Cubero M; Guardia J; Esteban R; Esteban JI.
Infect Drug Resist (Unknown)
Published: 2010
1/6 Transparent
Clinical perspective on aztreonam lysine for inhalation in patients with cystic fibrosis.
Daddario MK; Hagerman JK; Klepser ME.
Infect Drug Resist (Unknown)
Published: 2010
1/6 Transparent
Multidrug and extensively drug-resistant tuberculosis from a general practice perspective.
Yashodhara BM; Huat CB; Naik LN; Umakanth S; Hande M; Pappachan JM.
Infect Drug Resist (Unknown)
Published: 2010
1/6 Transparent
Extended use of raltegravir in the treatment of HIV-1 infection: optimizing therapy.
Charpentier C; Weiss L.
Infect Drug Resist (Unknown)
Published: 2010
1/6 Transparent
Daptomycin: a novel lipopeptide antibiotic against Gram-positive pathogens.
Beiras-Fernandez A; Vogt F; Sodian R; Weis F.
Infect Drug Resist (Unknown)
Published: 2010
2/6 Transparent
Funding Declared
Methicillin-resistant Staphylococcus aureus in HIV-infected patients.
Hidron AI; Kempker R; Moanna A; Rimland D.
Infect Drug Resist (Unknown)
Published: 2010
2/6 Transparent
Funding Declared
Long-term epidemiology of bacterial susceptibility profiles in adults suffering from febrile neutropenia with hematolog…
Mebis J; Jansens H; Minalu G; Molenberghs G; Schroyens W; Gadisseur A; van de Velde A; Vrelust I; Goossens H; Berneman Z.
Infect Drug Resist (Unknown)
Published: 2010
2/6 Transparent
Funding Declared
Role of posaconazole in the treatment of oropharyngeal candidiasis.
Ianas V; Matthias KR; Klotz SA.
Infect Drug Resist (Unknown)
Published: 2010
1/6 Transparent
Drug resistance in community-acquired respiratory tract infections: role for an emerging antibacterial.
Aguilar L; Giménez MJ; Barberán J.
Infect Drug Resist (Unknown)
Published: 2010
1/6 Transparent
Prevention strategies for antimicrobial resistance: a systematic review of the literature.
Caron WP; Mousa SA.
Infect Drug Resist (Unknown)
Published: 2010
1/6 Transparent
Raltegravir in combination with other antiretroviral agents for the treatment of HIV infection.
Chirch LM; Steigbigel RT.
Infect Drug Resist (Unknown)
Published: 2010
2/6 Transparent
Funding Declared
Doripenem in hospital infections: a focus on nosocomial pneumonia, complicated intra-abdominal infections, and complica…
Lo TS; Borchardt SM; Welch JM; Rohrich MA; Alonto AM; Alonto AV.
Infect Drug Resist (Unknown)
Published: 2009
1/6 Transparent
Evidence based approach to the treatment of community-associated methicillin-resistant Staphylococcus aureus.
Peppard WJ; Daniels A; Fehrenbacher L; Winner J.
Infect Drug Resist (Unknown)
Published: 2009
1/6 Transparent
New approaches in the management of chronic hepatitis B: role of tenofovir.
Reijnders JG; LA Janssen H.
Infect Drug Resist (Unknown)
Published: 2009
2/6 Transparent
Funding Declared
The determinants of the antibiotic resistance process.
Franco BE; Altagracia Martínez M; Sánchez Rodríguez MA; Wertheimer AI.
Infect Drug Resist (Unknown)
Published: 2009
1/6 Transparent
Micafungin in the treatment of invasive candidiasis and invasive aspergillosis.
Wiederhold NP; Cota JM; Frei CR.
Infect Drug Resist (Unknown)
Published: 2008
2/6 Transparent
Funding Declared
Expression of the MexXY-OprM efflux system in Pseudomonas aeruginosa with discordant cefepime/ceftazidime susceptibilit…
Laohavaleeson S; Lolans K; Quinn JP; Kuti JL; Nicolau DP.
Infect Drug Resist (Unknown)
Published: 2008
1/6 Transparent
Funding Declared
Characterization and antibiotic susceptibility of Listeria monocytogenes isolated from poultry and red meat in Morocco.
Ennaji H; Timinouni M; Ennaji MM; Hassar M; Cohen N.
Infect Drug Resist (Unknown)
Published: 2008